166 related articles for article (PubMed ID: 15993515)
1. Activity changes and marked stereotypic behavior precede Abeta pathology in TgCRND8 Alzheimer mice.
Ambrée O; Touma C; Görtz N; Keyvani K; Paulus W; Palme R; Sachser N
Neurobiol Aging; 2006 Jul; 27(7):955-64. PubMed ID: 15993515
[TBL] [Abstract][Full Text] [Related]
2. Wheel-running in a transgenic mouse model of Alzheimer's disease: protection or symptom?
Richter H; Ambrée O; Lewejohann L; Herring A; Keyvani K; Paulus W; Palme R; Touma C; Schäbitz WR; Sachser N
Behav Brain Res; 2008 Jun; 190(1):74-84. PubMed ID: 18342378
[TBL] [Abstract][Full Text] [Related]
3. Age- and sex-dependent development of adrenocortical hyperactivity in a transgenic mouse model of Alzheimer's disease.
Touma C; Ambrée O; Görtz N; Keyvani K; Lewejohann L; Palme R; Paulus W; Schwarze-Eicker K; Sachser N
Neurobiol Aging; 2004 Aug; 25(7):893-904. PubMed ID: 15212843
[TBL] [Abstract][Full Text] [Related]
4. Inflammation occurs early during the Abeta deposition process in TgCRND8 mice.
Dudal S; Krzywkowski P; Paquette J; Morissette C; Lacombe D; Tremblay P; Gervais F
Neurobiol Aging; 2004 Aug; 25(7):861-71. PubMed ID: 15212840
[TBL] [Abstract][Full Text] [Related]
5. Amyloid beta and impairment in multiple memory systems in older transgenic APP TgCRND8 mice.
Hanna A; Horne P; Yager D; Eckman C; Eckman E; Janus C
Genes Brain Behav; 2009 Oct; 8(7):676-84. PubMed ID: 19531156
[TBL] [Abstract][Full Text] [Related]
6. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
7. Metallothionein-I and -III expression in animal models of Alzheimer disease.
Carrasco J; Adlard P; Cotman C; Quintana A; Penkowa M; Xu F; Van Nostrand WE; Hidalgo J
Neuroscience; 2006 Dec; 143(4):911-22. PubMed ID: 17027170
[TBL] [Abstract][Full Text] [Related]
8. Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease.
Pugh PL; Richardson JC; Bate ST; Upton N; Sunter D
Behav Brain Res; 2007 Mar; 178(1):18-28. PubMed ID: 17229472
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
[TBL] [Abstract][Full Text] [Related]
10. Impaired conditioned taste aversion learning in APP transgenic mice.
Janus C; Welzl H; Hanna A; Lovasic L; Lane N; St George-Hyslop P; Westaway D
Neurobiol Aging; 2004 Oct; 25(9):1213-9. PubMed ID: 15312967
[TBL] [Abstract][Full Text] [Related]
11. Altered circadian locomotor activity in APP23 mice: a model for BPSD disturbances.
Vloeberghs E; Van Dam D; Engelborghs S; Nagels G; Staufenbiel M; De Deyn PP
Eur J Neurosci; 2004 Nov; 20(10):2757-66. PubMed ID: 15548219
[TBL] [Abstract][Full Text] [Related]
12. Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease.
El Tannir El Tayara N; Delatour B; Le Cudennec C; Guégan M; Volk A; Dhenain M
Neurobiol Dis; 2006 Apr; 22(1):199-208. PubMed ID: 16337798
[TBL] [Abstract][Full Text] [Related]
13. Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress.
Lee KW; Kim JB; Seo JS; Kim TK; Im JY; Baek IS; Kim KS; Lee JK; Han PL
J Neurochem; 2009 Jan; 108(1):165-75. PubMed ID: 19012747
[TBL] [Abstract][Full Text] [Related]
14. Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease.
Donovan MH; Yazdani U; Norris RD; Games D; German DC; Eisch AJ
J Comp Neurol; 2006 Mar; 495(1):70-83. PubMed ID: 16432899
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM
Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026
[TBL] [Abstract][Full Text] [Related]
16. A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition.
Flood DG; Lin YG; Lang DM; Trusko SP; Hirsch JD; Savage MJ; Scott RW; Howland DS
Neurobiol Aging; 2009 Jul; 30(7):1078-90. PubMed ID: 18053619
[TBL] [Abstract][Full Text] [Related]
17. Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice.
Knobloch M; Konietzko U; Krebs DC; Nitsch RM
Neurobiol Aging; 2007 Sep; 28(9):1297-306. PubMed ID: 16876915
[TBL] [Abstract][Full Text] [Related]
18. Progressive neuronal loss and behavioral impairments of transgenic C57BL/6 inbred mice expressing the carboxy terminus of amyloid precursor protein.
Lee KW; Im JY; Song JS; Lee SH; Lee HJ; Ha HY; Koh JY; Gwag BJ; Yang SD; Paik SG; Han PL
Neurobiol Dis; 2006 Apr; 22(1):10-24. PubMed ID: 16289866
[TBL] [Abstract][Full Text] [Related]
19. Transgenic Alzheimer mice in a semi-naturalistic environment: more plaques, yet not compromised in daily life.
Lewejohann L; Reefmann N; Widmann P; Ambrée O; Herring A; Keyvani K; Paulus W; Sachser N
Behav Brain Res; 2009 Jul; 201(1):99-102. PubMed ID: 19428622
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia increases Abeta generation by altering beta- and gamma-cleavage of APP.
Li L; Zhang X; Yang D; Luo G; Chen S; Le W
Neurobiol Aging; 2009 Jul; 30(7):1091-8. PubMed ID: 18063223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
